Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
N-Des-2-methylpropan-2-ol Docetaxel is an impur...
Caffeic acid ester found in Melissa, Salvia, an...
Neuroactive mycotoxin produced by Penicillum an...
Phenol found in Zingiber; PPARγ agonist, 5-HT3...
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
TGFbeta receptor inhibitor
Purine derivative; CDK inhibitor.
Synthetic vasopressin derivative; V2R agonist.<...
Organosulfur found in cruciferous vegetables; a...
Microtubule polymerization inhibitor.
HIV and AIDS
Calcitonin-family peptide, involved in vasodila...
Allosteric inhibitor
14-α demethylase inhibitor.
Isoxazole derivative; HSP90 inhibitor.
c-Met inhibitor.
SGLT2 inhibitor
Aldose reductase inhibitor.
Thrombin inhibitor.
Xanthine derivative; PDE inhibitor.